Vitamin K and musculoskeletal health in postmenopausal women

Molecular Nutrition and Food Research

Volumn 58, Issue 8, 2014, Pages 1647-1657

  Hamidi, Maryam S ^a   Cheung, Angela M ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone; Cartilage; Osteoarthritis; Osteoporosis; Vitamin K

Indexed keywords

VITAMIN K GROUP;

AGING; ANIMAL; DIET THERAPY; FEMALE; HEALTH STATUS; HUMAN; METABOLISM; MUSCULOSKELETAL DEVELOPMENT; MUSCULOSKELETAL FUNCTION; MUSCULOSKELETAL SYSTEM; OSTEOARTHRITIS; OSTEOPOROSIS, POSTMENOPAUSAL; PATHOPHYSIOLOGY; POSTMENOPAUSE; VITAMIN K DEFICIENCY;

AGING; ANIMALS; FEMALE; HEALTH STATUS; HUMANS; MUSCULOSKELETAL DEVELOPMENT; MUSCULOSKELETAL PHYSIOLOGICAL PHENOMENA; MUSCULOSKELETAL SYSTEM; OSTEOARTHRITIS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; VITAMIN K; VITAMIN K DEFICIENCY;

EID: 84905400259     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300950     Document Type: Article

References (99)

1. Papaioannou, A., Kennedy, C. C., Dolovich, L., Lau, E., Adachi, J. D., Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 2007, 24, 37-55.
2. Ishida, Y., Vitamin K2. Clin. Calcium 2008, 18, 1476-1482.
3. Bergen, W. G., Mersmann, H. J., Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models. J. Nutr. 2005, 135, 2499-2502.
4. Gundberg, C. M., Lian, J. B., Booth, S. L., Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv. Nutr. 2012, 3, 149-157.
5. Vermeer, C., Vitamin K: the effect on health beyond coagulation-an overview. Food Nutr. Res. 2012, 56. doi: 10.3402/fnr.v56i0.5329.
6. Booth, S. L., Lichtenstein, A. H., O'Brien-Morse, M., McKeown, N. M. et al., Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am. J. Clin. Nutr. 2001, 74, 783-790.
7. Guralp, O., Erel, C. T., Effects of vitamin K in postmenopausal women: mini review. Maturitas 2014, 77, 294-299.
8. Booth, S. L., Suttie, J. W., Dietary intake and adequacy of vitamin K. J. Nutr. 1998, 128, 785-788.
9. Beulens, J. W., Booth, S. L., van den Heuvel, E. G., Stoecklin, E. et al., The role of menaquinones (vitamin K2) in human health. Br. J. Nutr. 2013, 110, 1357-1368.
10. Thijssen, H. H., Vervoort, L. M., Schurgers, L. J., Shearer, M. J., Menadione is a metabolite of oral vitamin K. Br. J. Nutr. 2006, 95, 260-266.
11. Garber, A. K., Binkley, N. C., Krueger, D. C., Suttie, J. W., Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. J. Nutr. 1999, 129, 1201-1203.
12. Booth, S. L., Roles for vitamin K beyond coagulation. Annu. Rev. Nutr. 2009, 29, 89-110.
13. Cheung, A. M., Tile, L., Lee, Y., Tomlinson, G. et al., Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med. 2008, 5, e196.
14. Kidd, P. M., Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy. Altern. Med. Rev. 2010, 15, 199-222.
15. Olson, R. E., Chao, J., Graham, D., Bates, M. W. et al., Total body phylloquinone and its turnover in human subjects at two levels of vitamin K intake. Br. J. Nutr. 2002, 87, 543-553.
16. Shearer, M. J., Fu, X., Booth, S. L., Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv. Nutr. 2012, 3, 182-195.
17. Truong, J. T., Fu, X., Saltzman, E., Al Rajabi, A. et al., Age group and sex do not influence responses of vitamin K biomarkers to changes in dietary vitamin K. J. Nutr. 2012, 142, 936-941.
18. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Chapter 5. National Academy Press, Washington, DC 2001, pp. 162-196.
19. Braam, L. A., Knapen, M. H., Geusens, P., Brouns, F. et al., Factors affecting bone loss in female endurance athletes: a two-year follow-up study. Am. J. Sports Med. 2003, 31, 889-895.
20. Fang, Y., Hu, C., Tao, X., Wan, Y., Tao, F., Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. J. Bone Miner. Metab. 2012, 30, 60-68.
21. Stevenson, M., Lloyd-Jones, M., Papaioannou, D., Vitamin K to prevent fractures in older women: systematic review and economic evaluation. Health Technol. Assess. 2009, 13(iii-xi), 1-134.
22. Kohlmeier, M., Salomon, A., Saupe, J., Shearer, M. J., Transport of vitamin K to bone in humans. J. Nutr. 1996, 126, 1192S-1196S.
23. Sadowski, J. A., Hood, S. J., Dallal, G. E., Garry, P. J., Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. Am. J. Clin. Nutr. 1989, 50, 100-108.
24. Kaneki, M., Hosoi, T., Ouchi, Y., Orimo, H., Pleiotropic actions of vitamin K: protector of bone health and beyond? Nutrition 2006, 22, 845-852.
25. Natural Standard Database Professional Monograph, Vitamin K. Natural standard: the authority on integrative medicine, Somerville, MA, 2014. Available from (https://naturalmedicines.therapeuticresearch.com/databases/food, -herbs-supplements/v/vitamin-k/professional.aspx).
26. Traber, M. G., Vitamin E and K interactions-a 50-year-old problem. Nutr. Rev. 2008, 66, 624-629.
27. Misra, D., Booth, S. L., Tolstykh, I., Felson, D. T. et al., Vitamin K deficiency is associated with incident knee osteoarthritis. Am. J. Med. 2013, 126, 243-248.
28. Neogi, T., Booth, S. L., Zhang, Y. Q., Jacques, P. F. et al., Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 2006, 54, 1255-1261.
29. Oka, H., Akune, T., Muraki, S., En-yo, Y. et al., Association of low dietary vitamin K intake with radiographic knee osteoarthritis in the Japanese elderly population: dietary survey in a population-based cohort of the ROAD study. J. Orthop. Sci. 2009, 14, 687-692.
30. Vermeer, C., Theuwissen, E., Vitamin K, osteoporosis and degenerative diseases of ageing. Menopause Int. 2011, 17, 19-23.
31. Saltzman, J. R., Russell, R. M., The aging gut. Nutritional issues. Gastroenterol. Clin. N. Am. 1998, 27, 309-324.
32. Hodges, S. J., Pilkington, M. J., Shearer, M. J., Bitensky, L. et al., Age-related changes in the circulating levels of congeners of vitamin K2, menaquinone-7 and menaquinone-8. Clin. Sci. 1990, 78, 63-66.
33. Hodges, S. J., Bejui, J., Leclercq, M., Delmas, P. D., Detection and measurement of vitamins K1 and K2 in human cortical and trabecular bone. J. Bone Miner. Res. 1993, 8, 1005-1008.
34. Hauschka, P. V., Lian, J. B., Gallop, P. M., Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc. Natl. Acad. Sci. USA 1975, 72, 3925-3929.
35. Price, P. A., Otsuka, A. A., Poser, J. W., Kristaponis, J., Raman, N., Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc. Natl. Acad. Sci. USA 1976, 73, 1447-1451.
36. Ingram, R. T., Park, Y. K., Clarke, B. L., Fitzpatrick, L. A., Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling. J. Clin. Invest. 1994, 93, 989-997.
37. Price, P. A., Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function. Vitam. Horm. 1985, 42, 65-108.
38. Lee, N. K., Sowa, H., Hinoi, E., Ferron, M. et al., Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130, 456-469.
39. Ferron, M., Hinoi, E., Karsenty, G., Ducy, P., Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. USA 2008, 105, 5266-5270.
40. Karsenty, G., Ferron, M., The contribution of bone to whole-organism physiology. Nature 2012, 481, 314-320.
41. Price, P. A., Gla-containing proteins of bone. Connect. Tissue Res. 1989, 21, 51-57; discussion 57-60.
42. Shea, M. K., Holden, R. M., Vitamin K status and vascular calcification: evidence from observational and clinical studies. Adv. Nutr. 2012, 3, 158-165.
43. Luo, G., Ducy, P., McKee, M. D., Pinero, G. J. et al., Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386, 78-81.
44. Cancela, M. L., Price, P. A., Retinoic acid induces matrix Gla protein gene expression in human cells. Endocrinology 1992, 130, 102-108.
45. Oliva, A., Della Ragione, F., Fratta, M., Marrone, G. et al., Effect of retinoic acid on osteocalcin gene expression in human osteoblasts. Biochem. Biophys. Res. Commun. 1993, 191, 908-914.
46. Maillard, C., Berruyer, M., Serre, C. M., Dechavanne, M. et al., Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts. Endocrinology 1992, 130, 1599-1604.
47. Boskey, A. L., Gadaleta, S., Gundberg, C., Doty, S. B. et al., Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998, 23, 187-196.
48. Ducy, P., Desbois, C., Boyce, B., Pinero, G. et al., Increased bone formation in osteocalcin-deficient mice. Nature 1996, 382, 448-452.
49. Price, P. A., Baukol, S. A., 1, 25-Dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein. Biochem. Biophys. Res. Commun. 1981, 99, 928-935.
50. Bolton-Smith, C., McMurdo, M. E., Paterson, C. R., Mole, P. A. et al., Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J. Bone Miner. Res. 2007, 22, 509-519.
51. Gundberg, C. M., Nieman, S. D., Abrams, S., Rosen, H., Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J. Clin. Endocrinol. Metab. 1998, 83, 3258-3266.
52. Binkley, N. C., Krueger, D. C., Kawahara, T. N., Engelke, J. A. et al., A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am. J. Clin. Nutr. 2002, 76, 1055-1060.
53. Shea, M. K., Booth, S. L., Massaro, J. M., Jacques, P. F. et al., Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham offspring study. Am. J. Epidemiol. 2008, 167, 313-320.
54. Li, J., Wang, H., Rosenberg, P. A., Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes. J. Neurosci. Res. 2009, 87, 1997-2005.
55. Falcone, T. D., Kim, S. S., Cortazzo, M. H., Vitamin K: fracture prevention and beyond. PM R 2011, 3, S82-S87.
56. Braam, L. A., Knapen, M. H., Geusens, P., Brouns, F. et al., Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif. Tissue Int. 2003, 73, 21-26.
57. Yamaguchi, M., Uchiyama, S., Tsukamoto, Y., Stimulatory effect of menaquinone-7 on bone formation in elderly female rat femoral tissues in vitro: prevention of bone deterioration with aging. Int. J. Mol. Med. 2002, 10, 729-733.
58. Iwamoto, J., Takeda, T., Ichimura, S., Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis. Keio J. Med. 2003, 52, 147-150.
59. Hart, J. P., Catterall, A., Dodds, R. A., Klenerman, L. et al., Circulating vitamin K1 levels in fractured neck of femur. Lancet 1984, 2, 283.
60. Klenerman, L., Ferris, B. D., Hart, J. P., Vitamin K1 levels in proximal femoral fractures: brief report. J. Bone Joint Surg. Br. 1988, 70, 286.
61. Bitensky, L., Hart, J. P., Catterall, A., Hodges, S. J. et al., Circulating vitamin K levels in patients with fractures. J. Bone Joint Surg. Br. 1988, 70, 663-664.
62. Hart, J. P., Shearer, M. J., Klenerman, L., Catterall, A. et al., Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J. Clin. Endocrinol. Metab. 1985, 60, 1268-1269.
63. Hodges, S. J., Akesson, K., Vergnaud, P., Obrant, K. et al., Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J. Bone Miner. Res. 1993, 8, 1241-1245.
64. Hodges, S. J., Pilkington, M. J., Stamp, T. C., Catterall, A. et al., Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 1991, 12, 387-389.
65. Apalset, E. M., Gjesdal, C. G., Eide, G. E., Tell, G. S., Intake of vitamin K1 and K2 and risk of hip fractures: the Hordaland Health Study. Bone 2011, 49, 990-995.
66. Booth, S. L., Tucker, K. L., Chen, H., Hannan, M. T. et al., Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am. J. Clin. Nutr. 2000, 71, 1201-1208.
67. Feskanich, D., Weber, P., Willett, W. C., Rockett, H. et al., Vitamin K intake and hip fractures in women: a prospective study. Am. J. Clin. Nutr. 1999, 69, 74-79.
68. Chan, R., Leung, J., Woo, J., No association between dietary vitamin K intake and fracture risk in Chinese community-dwelling older men and women: a prospective study. Calcif. Tissue Int. 2012, 90, 396-403.
69. Rejnmark, L., Vestergaard, P., Charles, P., Hermann, A. P. et al., No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos. Int. 2006, 17, 1122-1132.
70. Hamidi, M. S., Gajic-Veljanoski, O., Cheung, A. M., Vitamin K and bone health. J. Clin. Densitom. 2013, 16, 409-413.
71. Cockayne, S., Adamson, J., Lanham-New, S., Shearer, M. J. et al., Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch. Intern. Med. 2006, 166, 1256-1261.
72. Inoue, T., Fujita, T., Kishimoto, H., Makino, T. et al., Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules. J. Bone. Miner. Metab. 2009, 27, 66-75.
73. Knapen, M. H., Drummen, N. E., Smit, E., Vermeer, C. et al., Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos. Int. 2013, 24, 2499-2507.
74. Booth, S. L., Broe, K. E., Gagnon, D. R., Tucker, K. L. et al., Vitamin K intake and bone mineral density in women and men. Am. J. Clin. Nutr. 2003, 77, 512-516.
75. Macdonald, H. M., McGuigan, F. E., Lanham-New, S. A., Fraser, W. D. et al., Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am. J. Clin. Nutr. 2008, 87, 1513-1520.
76. Fujita, Y., Iki, M., Tamaki, J., Kouda, K. et al., Association between vitamin K intake from fermented soybeans, natto, and bone mineral density in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos. Int. 2012, 23, 705-714.
77. Ikeda, Y., Iki, M., Morita, A., Kajita, E. et al., Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study. J. Nutr. 2006, 136, 1323-1328.
78. Troy, L. M., Jacques, P. F., Hannan, M. T., Kiel, D. P. et al., Dihydrophylloquinone intake is associated with low bone mineral density in men and women. Am. J. Clin. Nutr. 2007, 86, 504-508.
79. Kanai, T., Takagi, T., Masuhiro, K., Nakamura, M. et al., Serum vitamin K level and bone mineral density in post-menopausal women. Int. J. Gynaecol. Obstet. 1997, 56, 25-30.
80. Binkley, N. C., Krueger, D. C., Engelke, J. A., Foley, A. L. et al., Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults. Am. J. Clin. Nutr. 2000, 72, 1523-1528.
81. Binkley, N., Harke, J., Krueger, D., Engelke, J. et al., Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J. Bone Miner. Res. 2009, 24, 983-991.
82. Bugel, S., Sorensen, A. D., Hels, O., Kristensen, M. et al., Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women. Br. J. Nutr. 2007, 97, 373-380.
83. Kruger, M. C., Booth, C. L., Coad, J., Schollum, L. M. et al., Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women. Nutrition 2006, 22, 1120-1128.
84. Knapen, M. H., Schurgers, L. J., Vermeer, C., Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos. Int. 2007, 18, 963-972.
85. Ninomiya, J. T., Tracy, R. P., Calore, J. D., Gendreau, M. A. et al., Heterogeneity of human bone. J. Bone Miner. Res. 1990, 5, 933-938.
86. Cheung, A. M., Adachi, J. D., Hanley, D. A., Kendler, D. L. et al., High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group. Curr. Osteoporos. Rep. 2013, 11, 136-146.
87. Wallin, R., Schurgers, L. J., Loeser, R. F., Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in chondrocytes: a fetuin-MGP protein complex is assembled in vesicles shed from normal but not from osteoarthritic chondrocytes. Osteoarthritis Cartilage 2010, 18, 1096-1103.
88. Misra, D., Booth, S. L., Crosier, M. D., Ordovas, J. M. et al., Matrix Gla protein polymorphism, but not concentrations, is associated with radiographic hand osteoarthritis. J. Rheumatol. 2011, 38, 1960-1965.
89. Ohsaki, Y., Shirakawa, H., Miura, A., Giriwono, P. E. et al., Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor kappa B through the repression of IKK alpha/beta phosphorylation. J. Nutr. Biochem. 2010, 21, 1120-1126.
90. Hara, K., Akiyama, Y., Tajima, T., Shiraki, M., Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J. Bone Miner. Res. 1993, 8, 535-542.
91. Roberts, N. B., Holding, J. D., Walsh, H. P., Klenerman, L. et al., Serial changes in serum vitamin K1, triglyceride, cholesterol, osteocalcin and 25-hydroxyvitamin D3 in patients after hip replacement for fractured neck of femur or osteoarthritis. Eur. J. Clin. Invest. 1996, 26, 24-29.
92. Neogi, T., Felson, D. T., Sarno, R., Booth, S. L., Vitamin K in hand osteoarthritis: results from a randomised clinical trial. Ann. Rheum. Dis. 2008, 67, 1570-1573.
93. Tabb, M. M., Sun, A., Zhou, C., Grun, F. et al., Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J. Biol. Chem. 2003, 278, 43919-43927.
94. Spronk, H. M., Soute, B. A., Schurgers, L. J., Thijssen, H. H. et al., Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J. Vasc. Res. 2003, 40, 531-537.
95. Geleijnse, J. M., Vermeer, C., Grobbee, D. E., Schurgers, L. J. et al., Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J. Nutr. 2004, 134, 3100-3105.
96. Thijssen, H. H., Drittij-Reijnders, M. J., Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br. J. Nutr. 1996, 75, 121-127.
97. Shearer, M. J., Newman, P., Metabolism and cell biology of vitamin K. Thromb. Haemost. 2008, 100, 530-547.
98. Schurgers, L. J., Teunissen, K. J., Hamulyak, K., Knapen, M. H. et al., Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007, 109, 3279-3283.
99. Moschonis, G., Kanellakis, S., Papaioannou, N., Schaafsma, A. et al., Possible site-specific effect of an intervention combining nutrition and lifestyle counselling with consumption of fortified dairy products on bone mass: the Postmenopausal Health Study II. J. Bone Miner. Metab. 2011, 29, 501-506.